<!DOCTYPE html>
<html lang="en">
    <head>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="viewport" content="width=device-width, initial-scale=1">

        <meta content="Mustafaoglu Lab" name="Mustafaoglu Lab @ Sabanci University">
        <meta content="Nur Mustafaoglu, Sabanci University" name="keywords">
        <meta content="Copyright (c) 2020 Onur Varol" name="Copyright">
        <meta content="text/html; charset=utf-8" http-equiv="Content-Type">
        <meta property="og:title" content="Mustafaoglu Lab @ Sabanci University">
        <meta property="og:type" content="website">
        <meta property="og:url" content="http://mustafaoglulab.com/">
        <meta property="og:image" content="http://mustafaoglulab.com/img/mustafaoglu-lab-logo.png">
        <meta property="og:image:type" content="image/png">
        <meta property="og:image:width" content="400">
        <meta property="og:image:height" content="400">
        <meta property="og:description" content="This site contains information about Mustafaoglu Lab.">
        <link id="page_favicon" href="/img/favicon.ico" rel="icon" type="image/x-icon" />
        
        <link rel="stylesheet" href="/css/bootstrap.min.css">
        <script src="/js/jquery.min.js"></script>
        <script src="/js/popper.min.js"></script>
        <script src="/js/bootstrap.min.js"></script>
        <script src="/js/fa-all.js" data-auto-replace-svg="nest"></script>

        <link type="text/css" rel="stylesheet" href="/css/custom.css" />
        <link type="text/css" rel="stylesheet" href="/css/hover-min.css" />
        <link type="text/css" rel="stylesheet" href="/css/academicons.min.css" />

        <title>Mustafaoglu Lab Website</title>

        <script type="text/javascript">
            $(document).ready(function () {
                $('[data-toggle="tooltip"]').tooltip(); 
                $('#header-container').load('/template_header.html');
                $('#footer-container').load('/template_footer.html');
            });
        </script>

    </head>

    <body>
        <div id="header-container"></div>
        <div class="jumbotron" style="background-image: url(/img/ProFFIle-banner.png);"></div>

        <div class="container">
            <div class="row">
                <nav style="--bs-breadcrumb-divider: url(&#34;data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='8' height='8'%3E%3Cpath d='M2.5 0L1 1.5 3.5 4 1 6.5 2.5 8l4-4-4-4z' fill='currentColor'/%3E%3C/svg%3E&#34;);" aria-label="breadcrumb">
                  <ol class="breadcrumb">
                    <li class="breadcrumb-item"><a href="/research.html">Research</a></li>
                    <li class="breadcrumb-item active" aria-current="page">ProFFIle</li>
                  </ol>
                </nav>
            </div>

            <div class="row">
                <div class="col">
                <h4>Prodromal biomarkers in fatal familial insomnia: a longitudinal study in humans and mice</h4>
                <p>Human prion diseases are rare neurodegenerative disorders caused by prion protein (PrP) misfolding, which typically lead to death within a year from onset. Their rapid progression represents a challenge for therapy, as symptomatic patients may be profoundly debilitated by the time of diagnosis and treatment. Asymptomatic individuals with PrP mutations, many of which are highly penetrant, have the opportunity to be given treatments to prevent disease. However, biomarkers predictive of disease onset and/or progression are lacking, hampering design of preventive trials. The only preventive clinical trial underway (DOXIFF) involves carriers of the PrP mutation linked to fatal familial insomnia (FFI) and uses historical data to detect possible effects of doxycycline treatment on expected disease onset. This 10-year-long trial started in 2012 and results will be available next year. Brain-derived proteins, such as neurofilament light chain (NfL), tau and PrP, have been proposed to fill the unmet need for prodromal biomarkers and/or surrogate outcome measure in interventional studies, but their validity remains to be established.</br>
                In this project we aim to test proposed biomarkers in a large population of FFI individuals, and to carry out proteomic and metabolomic studies in extracellular vesicles (EVs) of CNS origin to identify disease-related signature(s) which may help understand FFI pathogenesis and serve as new biomarkers and/or potential targets for treatment. Specifically, we will: 1) measure plasma NfL, tau and PrP trajectories in well-characterized longitudinal cohorts of carriers of the FFI mutation, healthy at enrollment, who developed symptoms or are approaching the predicted age of disease onset, including individuals enrolled in the DOXIFF study; 2) optimize the RT-QuIC amplification technique to monitor the emergence of misfolded PrP in non-invasive FFI samples, such as urine and EV-enriched plasma fractions; 3) perform proteomic and metabolomic analysis of EVs purified from the plasma and culture media of iPSC-derived neurons from carriers of the FFI mutation to identify new potential biomarkers; and 4) correlate changes in plasma biomarker levels with the emergence and progression of behavioral disturbances and neuropathological changes in a FFI mouse model. These studies are expected to identify mechanistic biomarkers which could be used to predict the onset of symptoms and/or measure disease- modifying effects of pharmacological treatments in carriers of the FFI mutation.</p>
                </br>
                </div>
            </div>

            <div class="row">
                <div class="col">
                    <table class="table">
                    <tbody>
                        <tr>
                            <th>Funding Agency</th>
                            <td>
                                <a href="https://neurodegenerationresearch.eu/" target="_blank"><img width="200" height="100" alt="ERANET JPND" src="/img/research/JPND-logo.png"></a>
                            </td>
                        </tr>

                        <tr>
                            <th>Proje Duration</th>
                            <td>
                                <ul class="no-bullets">
                                    <li><span style="color:cadetblue;">Start day:</span> 1 June 2022</li>
                                    <li><span style="color:cadetblue;">End day:</span> Continue</li>
                                </ul>
                            </td>
                        </tr>

                        <tr>
                            <th>Consortium</th>
                            <td>
                                <ul class="no-bullets">
                                <li> <span style="color:cadetblue;">Coordinator:</span> Roberto Chiesa, Istituto di Ricerche Farmacologiche Mario Negri, Italy
                                    <a href="https://www.linkedin.com/in/roberto-chiesa-a9bb223/" target="_blank"><i class="fab fa-linkedin" style="color:#0e76a8;"></i></a></li>
                                <li> <span style="color:cadetblue;">PI:</span> Inga Zerr, Universitätsmedizin Göttingen, Germany
                                    <a href="https://www.dzne.de/en/research/research-areas/clinical-research/research-groups/zerr/research-areasfocus/" target="_blank"><i class="fab fa-home" style="color:#0e76a8;"></i></a></li>
                                <li> <span style="color:cadetblue;">PI:</span> Joaquín Castilla, Asociación Centro de Investigación Cooperativa en Biociencias (CIC bioGUNE), Spain
                                    <a href="https://www.cicbiogune.es/people/jcastilla" target="_blank"><i class="fab fa-home" style="color:#0e76a8;"></i></a></li>
                                <li> <span style="color:cadetblue;">PI:</span> Izaro Kortazar, Hospital Universitario Araba, Public Health, Spain
                                    <a href="https://www.osakidetza.euskadi.eus/osi-araba/-/osi-araba-hospital-universitario-presentacion/" target="_blank"><i class="fab fa-home" style="color:#0e76a8;"></i></a></li>
                                <li> <span style="color:cadetblue;">PI:</span> Fabio Moda, Fondazione IRCCS Istituto Neurologico Carlo Besta, Public Health, Italy
                                    <a href="https://www.istituto-besta.it/" target="_blank"><i class="fab fa-home" style="color:#0e76a8;"></i></a></li>
                                <li> <span style="color:cadetblue;">PI:</span> Nur Mustafaoglu, Sabanci University, Turkey
                                    <a href="https://www.linkedin.com/in/nurmustafaoglu/" target="_blank"><i class="fab fa-linkedin" style="color:#0e76a8;"></i></a></li>
                            </ul> 
                            </td>
                        </tr>

                        <tr>
                            <th>Turkish Team</th>
                            <td>
                                <ul class="no-bullets">
                                <li> <span style="color:cadetblue;">PI:</span> Nur Mustafaoglu, Sabanci University, Turkey
                                    <a href="https://www.linkedin.com/in/nurmustafaoglu/" target="_blank"><i class="fab fa-linkedin" style="color:#0e76a8;"></i></a></li>
                                <li> <span style="color:cadetblue;">Postdoc:</span> Gulnaz Yildirim Koken, Sabanci University Nanotechnology Research and Application Center (SUNUM), Turkey
                                    <a href="https://www.linkedin.com/in/g%C3%BClnaz-y%C4%B1ld%C4%B1r%C4%B1m-k%C3%B6ken-267bb9a8/" target="_blank"><i class="fab fa-linkedin" style="color:#0e76a8;"></i></a></li>
                                <li> <span style="color:cadetblue;">PhD Student:</span> Nafisa Tanjia, Sabanci University, Turkey</li>
                            </ul> 
                            </td>
                        </tr>

                        <tr>
                            <th>Publications</th>
                            <td>
                                <ul>
                                    <li></li>
                                </ul>
                            </td>
                        </tr>

                        <tr>
                            <th>Outreach</th>
                            <td>
                                <ul>    
                                    <li></li>
                                </ul> 
                            </td>
                        </tr>

                        <tr>
                            <th>News</th>
                            <td>
                                <ul>    
                                    <li></li>
                                </ul> 
                            </td>
                        </tr>
                    </tbody>
                    </table>
                </div>
            </div>
 
        </div>
        <div id="footer-container"></div>
    </body>

</html>